Physician profile
Lawrence Lemak
NPI 1851368757
$216,196.78
in general payments reported to CMS, 2019-2025
24 companies · $330 in 2025
The $330 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $146 · 2020: $175K · 2021: $40K · 2022: $16.62 · 2023: $253 · 2024: $264 · 2025: $330.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $847.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $847.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Anika Therapeutics, INC. | $212,994.45 | 2020-2021 | |
| Maruho Medical, INC. | $2,000.00 | 2020 | |
| Depuy Synthes Sales INC. | $405.04 | 2023-2025 | Dynacord, Healix Knotless Peek, Dynatape |
| Pacira Pharmaceuticals Incorporated | $194.92 | 2019-2025 | Zilretta, Exparel, Iovera |
| Smith+Nephew, INC. | $86.44 | 2023 | Journey II, Tandem |
| Pacira Therapeutics, INC. | $78.42 | 2019-2020 | |
| Ethicon US, LLC | $46.46 | 2024 | Vistaseal, Ethicon, Dermabond Prineo |
| Bioventus LLC | $43.23 | 2021-2025 | Xcell |
| Heraeus Medical, LLC. | $41.06 | 2020 | |
| Abbott Laboratories | $38.49 | 2021 | |
| Convatec INC. | $30.02 | 2025 | |
| Si-Bone, INC. | $27.79 | 2019-2021 | |
| Solventum Corporation | $27.52 | 2025 | Prevena, V.A.C. Veraflo |
| Dexcom, INC. | $23.76 | 2025 | Dexcom G6 Transmitter |
| Sanofi-Aventis U.S. LLC | $21.87 | 2019 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Orthofix Medical, INC. | $20.10 | 2019-2023 | Physio-Stim |
| Fidia Pharma USA INC. | $18.27 | 2019 | |
| Ferring Pharmaceuticals INC. | $17.93 | 2019 | |
| Heron Therapeutics, INC. | $17.68 | 2021 | |
| Ermi LLC | $17.01 | 2025 | |
| Kyowa Kirin, INC. | $16.62 | 2022 | |
| Zimmer Biomet Holdings, INC. | $15.15 | 2019 | |
| Baudax Bio INC. | $14.55 | 2021 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$151,201.00 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lawrence Lemak listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.